| Jessica Chang, PHARMD, APH | |
|
280 W Macarthur Blvd, Oakland, CA 94611-5642 | |
| (510) 752-8859 | |
| Not Available |
| Full Name | Jessica Chang |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 280 W Macarthur Blvd, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003220310 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 69436 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Chang, PHARMD, APH 280 W Macarthur Blvd, Oakland, CA 94611-5642 Ph: (510) 752-8859 | Jessica Chang, PHARMD, APH 280 W Macarthur Blvd, Oakland, CA 94611-5642 Ph: (510) 752-8859 |
News Archive
The creation of new federal policies requiring universities to maintain detailed records about specific laboratory chemicals deemed dangerous has presents new challenges for the nation's institutions of higher education and hospitals. Fortunately, Raleigh company, EasierTech Software, has developed the solution: the country's first online database software application designed for colleges and universities that generates chemical hygiene plans, required for OSHA, and tracks the Dept. of Homeland Security's target list of chemicals.
CytoSorbents Corporation, a critical care immunotherapy company using blood purification to treat life-threatening conditions, announced the launch of its International CytoSorb Treatment Registry, established and managed by the Center of Clinical Trials at the University of Jena, Germany.
Researchers at the University of Massachusetts Medical School believe they may have found a new treatment for retinitis pigmentosa, a severe neurodegenerative disease of the retina that ultimately results in blindness. One of the more common retinal degenerative diseases, RP is caused by the death of photoreceptor cells and affects 1 in 4,000 people in the United States. RP typically manifests in young adulthood as night blindness or a loss of peripheral vision and in many cases progresses to legal blindness by age 40.
Emergent BioSolutions Inc. today announced the initiation of a Phase Ib/II study (16201) of TRU-016 for chronic lymphocytic leukemia (CLL). TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP™) protein therapeutic in development for the treatment of B-cell malignancies. TRU-016 is being developed in collaboration with Abbott.
Casetabs announced today the preliminary launch of its mobile and desktop service for ambulatory surgery centers. Since a beta release in February, seven national surgery centers have implemented Casetabs to coordinate the communication and planning of their cases.
› Verified 9 days ago
Dr. Gachiru L Kamau-devers, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 Fruitvale Ave, Oakland, CA 94602 Phone: 510-336-9305 Fax: 510-336-3925 | |
Trong-nghia Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3320 Fruitvale Ave, Oakland, CA 94602 Phone: 510-530-3156 Fax: 510-530-1082 | |
Jocelyn Chan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Fl 13, Oakland, CA 94612 Phone: 510-625-2139 | |
Norma Miyeko Marubayashi Holloway, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6468 | |
Mrs. Michele Ng, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6141 | |
Carol K Lam, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Ste 1301, Oakland, CA 94612 Phone: 626-941-4706 |